Volume 24, Number 7—July 2018
Perspective
Progress in Vaccine-Preventable and Respiratory Infectious Diseases—First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006–2015
Figure 2

Figure 2. Selected immunization coverage by vaccine and target group, United States, 2005–2006 and 2015. PCV7 and PCV13 are >4 doses. Rotavirus coverage is 2 or 3 doses depending on product. PCV7 is a pneumococcal conjugate vaccine with 7 serotypes, and PCV13 is a pneumococcal conjugate vaccine with 13 serotypes. Data were obtained from the National Immunization Survey for toddlers, the National Immunization Survey-Teen (NIS-Teen) for adolescents, the National Immunization Survey-Flu for influenza, and the National Health Interview Survey for PPSV and zoster. DTaP, diphtheria, tetanus, and acellular pertussis vaccine; HPV, human papillomavirus vaccine; MCV, meningococcal conjugate vaccine; MMR, measles, mumps, and rubella vaccine; PCV, pneumococcal conjugate vaccine; PPSV, pneumococcal polysaccharide vaccine; Tdap, tetanus, diphtheria, and acellular pertussis vaccine.
1Current affiliation: Emory University, Atlanta, Georgia, USA.
2Current affiliation: World Health Organization, Cairo, Egypt.